24th November 2021, Christchurch, New Zealand

One of the world’s most experienced computer tomography (CT) engineers has joined the MARS Bioimaging team

Robert (Bob) Senzig is MARS Bioimaging’s new Vice President of Clinical Engineering – a position created to strengthen the company’s leadership team during a period of growth. 

MARS Bioimaging is a global leader in spectral molecular imaging research and development.  The group developed the world’s first commercial pre-clinical spectral photon counting CT scanner, and a specialist compact point-of-care wrist and hand scanner. MARS aims to achieve FDA (Food and Drug Administration) approval for the specialist wrist scanner by mid-2022.

Bob has more than 3 decades of experience designing CT scanning equipment. He was most recently GE Healthcare’s Global CT Chief Engineer.  

Bob says he is thrilled to be part of the future of imaging. “I have seen many innovations in imaging. Spectral imaging is the next step in CT scanning. The MARS spectral photon counting technology will truly impact point-of-care imaging.”

“MARS’s strategy really excites me. By entering the point-of-care market with spectral photon counting CT, we’ll be able to dominate this growing and strategically important market segment. No other point-of-care manufacturer has the level of technology that MARS has. Similarly, the market is traditionally under served by the larger companies. In a few years’ time, MARS will be the most important point-of-care imaging company.”

Bob has made significant contributions to the development of advanced medical imaging equipment with more than 3 decades of experience in innovative CT technologies. He joined GE Healthcare CT engineering in 1982. Bob has held senior leadership roles since the 1990s. As CT System Engineering Manager, he was involved from concept to product in several critical developments, including the first Solid State Detector CT, innovative Slipring CT, and Multi-slice CT. As Chief Engineer, he helped develop kV switching for Dual-Energy CT and Volume Cardiac CT system. Bob was instrumental in leading a global team developing a low-cost CT scanner for developing countries. He helped initiate photon counting experimental systems at the GE Haifa Engineering facility, GE Global Research Centre, and most recently with GE’s engineering group in Stockholm.

Bob’s most recent role was as the Chief Engineer of GE’s global CT engineering, held 2001 till retirement in 2018. He holds 50 patents and has been an author of numerous scientific publications.

MARS Bioimaging’s Chief Medical Officer Professor Anthony Butler said: “We are delighted Bob has agreed to join MARS Bioimaging. He is an outstanding expert in clinical imaging and brings to MARS broad experience of imaging technology and the critical role imaging plays in the patient care pathway.”

For more information, email communications officer Dr Chiara Lowe at info@marsbioimaging.com.